Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Pulmonary/Respiratory Diseases | Family Medicine
Disease Category: Non-Small Cell Lung Cancer
Location: United States, ND

Clinical Trial Details

Overview

Research Study Summary

Advanced Non-Small Cell Lung Cancer

Purpose

First-line induction and maintenance therapy for the treatment of patients with Stage IV NSCLC

Patient Inclusion Criteria:

  • Must have a histologic or cytologic diagnosis of advance NSCLC, may not have received any prior systemic chemotherapy, 18 + years of age

Patient Exclusion Criteria:

  • Have a known central nervous system disease, other than treated brain metastasis, had a major surgical procedure, is currently receiving ongoing treatment with full-dose warfarin, have inadequately controlled hypertension.

To Learn more
Phase

3

Gender

Both Male and Female

Age

18 and up

Overall Status

Recruiting

Facility Type

N/A

Contact

Dr. Tom Davis, Director of Business Development
Legacy Pharma Research
601 N. 5th St.
Bismarck, ND 58501
Phone: 701-751-1128
Fax: 701-751-1131

View Map

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 163097

Date Last Changed: July 24, 2013


DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.